Form D · Investing
Bioverge Funds, BV II, LLC
Boise, ID · CIK 0001839314
Offering snapshot reported Jan 6, 2021 · SEC filing
- Reported sold
- $35K Offering amount: $50K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Dec 30, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2021 | Initial | $35,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385445
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Bioverge Funds Management, LLC | None |
Source: Form D, filed Jan 6, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Bioverge Funds Management, Llc Littman | Executive |
Issuer details
Industry: Investing (See others in industry)
Address:
222 N 13 Th St
Boise, ID, 83702
Boise, ID, 83702